Phase II Dog Cancer Trial Commences
190909_Phase II Dog Cancer Trial Commences
30 August 2019 Top 20 Shareholders
Top Holders August 2019
Appendix 4E Preliminary Final Report
190830_Preliminary Final Report
Appendix 3B and s708 Notice
190828_Appendix 3B & s708 notice
Arrival of GMP Tablets for Phase II Dog Trials
190826_GMP Tablets Arrive_447v3rv314vgd9
Change of Director’s Interest Notice
190816_Change of Director's Interest Notice 447k299n9rnrts
31 July 2019 Top 20 Shareholders
190731_Top_Holders_Report (33)
Appendix 4C and Quarterly Update
4471277nx3858c
Appendix 3B & s708 Notice
190729_Unlisted Options Issuance
July 25 Investor Presentation
190725_PAA PRESENTATION 25 JULY 2019